NIH-funded research R01 grant

New methods for analyzing RNA molecules in cells

Official title: Direct RNA sequencing using electo-optical zero mode waveguides and custom click fluorescent nucleotides

Funded at Northeastern University · NIH-11044160 · Data updated 2026-11-12

This study is exploring new ways to read RNA directly, which could help us understand how it affects diseases like ALS and frontotemporal degeneration, and it aims to provide valuable insights that might benefit patients in the future.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNortheastern University
NIH-funded
Lab location1 site (Boston, United States)
Project startFebruary 27, 2024
Project endJanuary 31, 2028
Funding year2025
Award (this year)$1,068,064
NIH project number5R01HG013304-02
Project IDNIH-11044160 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with amyotrophic lateral sclerosis or frontotemporal dementia.

Less likely to help

Patients with conditions unrelated to RNA modifications or those not diagnosed with ALS or frontotemporal dementia may not benefit from this research.

What this research studies

This research focuses on developing advanced techniques for direct RNA sequencing using innovative optical technologies. By utilizing electro-optical zero mode waveguides and custom fluorescent nucleotides, the project aims to improve the understanding of RNA's role in biological processes, particularly in conditions like amyotrophic lateral sclerosis and frontotemporal degeneration. Patients may benefit from insights gained about RNA modifications and their implications for disease mechanisms. The approach involves analyzing RNA directly without converting it to DNA, allowing for a more accurate representation of RNA's chemical modifications.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and potential new treatments for diseases like ALS and frontotemporal dementia.

How similar studies have gone: Previous research has shown promise in RNA sequencing technologies, indicating potential for success in this novel approach.

Where this research is happening

  • Northeastern University
    Boston, United States
    Active

Researchers

  • Principal investigator: Wanunu, Meni — Northeastern University
  • Study coordinator: Wanunu, Meni

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.